Latest

07
Mar
Why European Startups Struggle to Woo Investors

Why European Startups Struggle to Woo Investors

Raising capital for a biotech startup in Europe is a bit like trying to sell an avant-garde art piece to
4 min read
06
Mar
The Halo Effect: Why We Keep Falling for Corporate Frauds (and Ignoring the Skeptics)

The Halo Effect: Why We Keep Falling for Corporate Frauds (and Ignoring the Skeptics)

There is a certain rhythm to corporate fraud. A charismatic figure appears, claiming to be disrupting an industry, armed with
3 min read
05
Mar
A Quick Guide to Understanding the Problems with Financial Metrics in Biotech and Pharma

A Quick Guide to Understanding the Problems with Financial Metrics in Biotech and Pharma

If you’re short on time and need to grasp the core issues with traditional financial metrics in biotech and
3 min read
04
Mar
The “Visionary” Delusion: Self-Appointed Prophets of the Obvious

The “Visionary” Delusion: Self-Appointed Prophets of the Obvious

In Greek mythology, King Midas wished that everything he touched would turn to gold. In corporate life, many have developed
3 min read
03
Mar
The Venture Capital Carousel: A Founder’s Tale of Money, Strings, and Shrinking Control

The Venture Capital Carousel: A Founder’s Tale of Money, Strings, and Shrinking Control

If venture capital were a relationship, it would be the kind of marriage arranged by a matchmaker who only gets
4 min read
02
Mar
The problem with IRR

The problem with IRR

The Internal Rate of Return (IRR) is beloved by private equity (PE) and venture capital (VC) firms, often regarded as
4 min read
01
Mar
The Trouble with TVPI, DPI, and RVPI

The Trouble with TVPI, DPI, and RVPI

Imagine this you’re an investor sitting in a polished conference room. The General Partner (GP) of a biotech-focused private
5 min read
28
Feb
Identifying Red Flags: Detailed Insights into Statistical Anomalies in Clinical Trial Data

Identifying Red Flags: Detailed Insights into Statistical Anomalies in Clinical Trial Data

Clinical trials serve as the cornerstone of evidence-based medicine, providing critical data to evaluate the safety and efficacy of therapeutic
4 min read
27
Feb
The VC Home Bias Problem: Why European Investors Refuse to Cross the Street

The VC Home Bias Problem: Why European Investors Refuse to Cross the Street

Venture capital, in theory, is about finding the best startups, wherever they may be. In practice? Many European VCs barely
3 min read
26
Feb
The Corporate Award Industrial Complex: A Trophy for Everyone

The Corporate Award Industrial Complex: A Trophy for Everyone

There are few things as vague yet self-important as the phrase “award-winning”. It’s a flex, a flourish, a signal
4 min read